SonoThera Appoints Carolyne Zimmermann as Chief Business Officer
SonoThera announced the appointment of Carolyne Zimmermann as its Chief Business Officer. Carolyne brings over 20 years of experience in business development and leadership roles in the pharmaceutical and biotechnology industry. She most recently served as the Chief Business Officer for 4D Molecular Therapeutics (4DMT).
SonoThera is a healthcare company focused on developing innovative therapeutic solutions.